Yuval Cabilly - Insider Trading & Ownership

Entity
Individual
Location
C/O Biosight Therapeutics, 4 Hasadot Street, Ramat Hasharon, Israel
Summary
The estimated net worth of Yuval Cabilly is at least $271K dollars as of November 8, 2023. Yuval Cabilly is the Director of Ayala Pharmaceuticals, Inc. and owns shares of Ayala Pharmaceuticals, Inc. (ADXS) stock worth about $271K.
All Insider Reports
All Insider Reports

Ownership of Yuval Cabilly

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ADXS Ayala Pharmaceuticals, Inc. Director $271K Oct 18, 2023

There are no insider transactions reported by Yuval Cabilly